Weld Capital Management’s Core Laboratories CLB Stock Holding History

Weld Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,561	Closed	-$1.15M	–	471
2019 Q4	$1.15M	Buy	+30,561	New	+$1.37M	0.22%	162
2019 Q3	–	Sell	-14,342	Closed	-$750K	–	795
2019 Q2	$750K	Buy	+14,342	New	+$841K	0.14%	257
2019 Q1	–	Sell	-4,925	Closed	-$294K	–	683
2018 Q4	$294K	Buy	+4,925	New	+$425K	0.07%	500

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Weld Capital Management's CLB Position: Q1 2020 in Review

Weld Capital Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 30,561 shares — an estimated $1.15M sold.

Weld Capital Management first reported a position in CLB in Q4 2018 and held it in 3 quarters. The position peaked at $1.15M in Q4 2019. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Weld Capital Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Weld Capital Management sold 30,561 Core Laboratories shares in Q1 2020, an estimated $1.15M.
Weld Capital Management first reported a position in Core Laboratories in Q4 2018 and held it in 3 quarters.
Weld Capital Management's Core Laboratories position peaked at $1.15M in Q4 2019.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Weld Capital Management's 13F filing for Q1 2020, filed 15 May 2020.